A biotech company accelerating the clinical development of innovative vaccine products
Established inNovember 2017.
Address1616 Eastlake Avenue East Suite 290, Seattle WA 98102
Curevo is a Seattle-based biotech company that is currently conducting clinical trials on the next-generation vaccine against varicella zoster (CRV101).
The company is transforming itself into a future leader of the global vaccine market, conducting clinical trials on a wide range of innovative vaccines against a variety of infectious and contagious diseases.
Through partnership with the world-class Infectious Disease Research Institute (IDRI), Curevo continues to augment its expertise.